Hugh Mostafid

Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial

Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman et al. · European Urology · 2022 · 57 citations · Full text

A Randomized Trial of PHOTOdynamic Surgery in Non–Muscle-Invasive Bladder Cancer

Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo et al. · NEJM Evidence · 2022 · 54 citations · Full text

Surgical Oncology, Multimodality, Bladder Tumor +16

Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer

Olga M Pijpers, Kees Hendricksen, Hugh Mostafid et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 38 citations · Full text

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance

S. Hafeez, Amanda Webster, Vibeke N. Hansen et al. · BMJ Open · 2020 · 34 citations · Full text

En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting

Jeremy Yuen‐Chun Teoh, Nikhil Mayor, Kai-Man Li et al. · World Journal of Urology · 2021 · 26 citations

Urology, Surgical Oncology, Bladder Tumour +8